LON:MTFBMotif Bio Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Motif Bio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 0.86 -0.04 (-4.42 %) (As of 05/25/2020 04:15 AM ET) Add Compare Share Today's Range 0.70Now: GBX 0.87▼ 0.9550-Day Range 0.05MA: GBX 0.45▼ 1.4952-Week Range 0.03Now: GBX 0.87▼ 10.05Volume35.18 million shsAverage Volume400,302 shsMarket Capitalization£5.60 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInsider TradesHeadlines Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Motif Bio. Previous Next 3.0 Community Rank Outperform VotesMotif Bio has received 369 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMotif Bio has received 254 “underperform” votes. (Add your “underperform” vote.)Community SentimentMotif Bio has received 59.23% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Motif Bio and other stocks. Vote “Outperform” if you believe MTFB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMotif Bio does not currently pay a dividend.Dividend GrowthMotif Bio does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Motif Bio insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Motif Bio are expected to grow in the coming year, from GBX (22.17) to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Motif Bio is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Motif Bio is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.73 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:MTFB Previous Symbol CUSIPN/A CIKN/A Webwww.motifbio.com Phone609-608-0032Debt Debt-to-Equity RatioN/A Current Ratio0.26 Quick Ratio0.20Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.46 per share Price / Cash Flow1.89 Book ValueGBX (3.20) per share Price / Book-0.27Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees8 Outstanding Shares647,848,000Market Cap£5.60 million Next Earnings DateN/A OptionableNot Optionable LSE:MTFB Rates by TradingView Receive MTFB News and Ratings via Email Sign-up to receive the latest news and ratings for MTFB and its competitors with MarketBeat's FREE daily newsletter. Motif Bio (LON:MTFB) Frequently Asked Questions How has Motif Bio's stock been impacted by COVID-19 (Coronavirus)? Motif Bio's stock was trading at GBX 0.13 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MTFB stock has increased by 583.8% and is now trading at GBX 0.87. View which stocks have been most impacted by Coronavirus. Has Motif Bio been receiving favorable news coverage? News coverage about MTFB stock has trended extremely negative on Monday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Motif Bio earned a news impact score of -4.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View the latest news aboutMotif Bio. Who are some of Motif Bio's key competitors? Some companies that are related to Motif Bio include Actinogen Medical (ACW), Galena Biopharma (SLS), Exopharm (EX1), Oragenics (OGEN), Redx Pharma (REDX), BTC Health (BTC), Regeneus (RGS), Nyrada (NYR), C4X Discovery (C4XD), Cellmid (CDY), Can-Fite Biopharma (CANF), Prescient Therapeutics (PTX), Inhibitor Therapeutics (INTI), ContraVir Pharmaceuticals (HEPA) and Agronomics (ANIC). View all competitors. What other stocks do shareholders of Motif Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Motif Bio investors own include Hawkins (HWKN), CA (CA), Sirius Minerals (SXX), Egdon Resources (EDR), BlackRock (BLK), Endologix (ELGX), Global Blood Therapeutics (GBT), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG) and Aegean Marine Petroleum Network (ANW). Who are Motif Bio's key executives? Motif Bio's management team includes the following people: Mr. Graham George Lumsden, CEO & Exec. Director (Age 59)Mr. Jonathan E. Gold, CFO & Exec. Director (Age 46)Dr. David B. Huang, Chief Medical Officer (Age 44)Mr. Robert Dickey IV, Advisor (Age 63)Laurie Doyle, Head of Investor Relations & Corp. Communications What is Motif Bio's stock symbol? Motif Bio trades on the London Stock Exchange (LON) under the ticker symbol "MTFB." How do I buy shares of Motif Bio? Shares of MTFB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Motif Bio's stock price today? One share of MTFB stock can currently be purchased for approximately GBX 0.87. How big of a company is Motif Bio? Motif Bio has a market capitalization of £5.60 million. Motif Bio employs 8 workers across the globe. What is Motif Bio's official website? The official website for Motif Bio is www.motifbio.com. How can I contact Motif Bio? Motif Bio's mailing address is One Tudor Street, LONDON, EC4Y 0AH, United Kingdom. The company can be reached via phone at 609-608-0032. This page was last updated on 5/25/2020 by MarketBeat.com Staff
